Skip to main content

Table 3 The sensitivity analysis excluded the studies considered to contribute the most heterogeneity

From: Comparison of clinical outcomes and complications between endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative diseases: a systematic review and meta-analysis

Results and subgroup analysis

Number of studies

Exclusion study

Heterogeneity

P (overall effect test)

x2

I2, %

P

 

1.1 Lumbar VAS score

 1.1.1Postoperative ≤ 2 weeks

7

Lim, 2022

5.43

8%

0.37

 < 0.00001

 1.1.2 Post 3 months

5

Han, 2022

5.05

41%

0.17

 < 0.00001

 1.1.3 Final FU

10

Chang, 2022

0.98

0%

1.00

 = 0.04

1.2 Preoperative (lower extremity pain VAS score)

7

Ge, 2022

0.02

27%

0.23

 = 0.58

1.3 ODI score

 1.3.1 Post 3 months

5

Zhang, 2021

3.44

13%

0.33

 = 0.17

 1.3.1 Post 6 months

3

Zhang, 2021

0.00

0%

0.96

 = 0.17